title: Widespread expression of chondroitin sulfate-type serglycins with CD44 binding ability in hematopoietic cells.
abstract: Serglycin is a family of small proteoglycans with Ser-Gly dipeptide repeats and is modified with various types of glycosaminoglycan side chains. We previously demonstrated that chondroitin sulfate-modified serglycin is a novel ligand for CD44 involved in the adherence and activation of lymphoid cells. In this study, we investigated the production and distribution of CD44 binding serglycins in various hematopoietic cells and characterized their carbohydrate side chains. Immunoprecipitation analysis using CD44-IgG and polyclonal antibody against the serglycin core peptide demonstrated that various serglycin species capable of binding CD44 are produced by a variety of hematopoietic cells including lymphoid cells, myeloid cells, and a few tumor cell lines. Glycosaminoglycans on these serglycins, which are essential for CD44 binding, are composed of chondroitin 4-sulfate or a mixture of chondroitin 4-sulfate and chondroitin 6-sulfate, but no heparin or heparan sulfate side chain was detected. The serglycins are also secreted by normal splenocytes, lymph node lymphocytes, and bone marrow cells, whereas they are secreted in very small amounts by normal thymocytes. Secretion of serglycins is greatly enhanced by mitogenic stimulation with concanavalin A or lipopolysaccharide. Our results showed that serglycin, unlike hyaluronate, is produced and secreted in a functional (CD44 binding) form by many members of the hematopoietic system including various lymphocyte subsets. Our data suggest that serglycin may serve as a major ligand for CD44 in various events in the lymphohematopoietic system.
authors.affiliation: Department of Immunology, The Tokyo Metropolitan Institute of Medical Science, 3-18-22, Hon-Komagome, Bunkyo-ku, Tokyo, Japan. nsorimachi@rinshoken.or.jp
authors.forename: N
authors.initials: N
authors.lastname: Toyama-Sorimachi
authors.forename: F
authors.initials: F
authors.lastname: Kitamura
authors.forename: H
authors.initials: H
authors.lastname: Habuchi
authors.forename: Y
authors.initials: Y
authors.lastname: Tobita
authors.forename: K
authors.initials: K
authors.lastname: Kimata
authors.forename: M
authors.initials: M
authors.lastname: Miyasaka
mesh_terms: D000818:Animals; D001854:Bone Marrow Cells / Q000378:metabolism*; D002450:Cell Communication; D002460:Cell Line; D002809:Chondroitin Sulfates / Q000378:metabolism*; D005260:Female; D018960:Hyaluronan Receptors / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D011509:Proteoglycans / Q000235:genetics / Q000378:metabolism*; D011817:Rabbits; D014407:Tumor Cells, Cultured; D033921:Vesicular Transport Proteins
chemical_list: D018960:Hyaluronan Receptors; D011509:Proteoglycans; D033921:Vesicular Transport Proteins; C075430:serglycin; D002809:Chondroitin Sulfates